Zobrazeno 1 - 10
of 39
pro vyhledávání: '"T A, Esbenshade"'
Autor:
P. B. Jacobson, K. M. Krueger, R. S. Bitner, Marlon D. Cowart, M. E. Brune, T. A. Esbenshade, T. A. Fey, R. W. Dickinson, A. A. Hancock, S. Otte, V. E. Knourek-Segel, E. N. Bush, A. L. Nikkel, B. A. Droz, R. Shapiro
Publikováno v:
Inflammation Research. 55:S42-S44
Autor:
K P Minneman, T A Esbenshade
Publikováno v:
Annual Review of Pharmacology and Toxicology. 34:117-133
Investigators have not yet reached a consensus on the number and signaling mechanisms of alpha 1-adrenergic receptor (AR) subtypes. Two native subtypes (alpha 1A and alpha 1B) can be distinguished pharmacologically, and three subtypes (alpha 1B, alph
Publikováno v:
Japanese Journal of Pharmacology. 58:128-134
Autor:
T R, Miller, I, Milicic, J, Bauch, J, Du, B, Surber, K E, Browman, K, Marsh, M, Cowart, J D, Brioni, T A, Esbenshade
Publikováno v:
British journal of pharmacology. 157(1)
The histamine H3 receptor antagonist radioligand [3H]-A-349821 was characterized as a radiotracer for assessing in vivo receptor occupancy by H3 receptor antagonists that affect behaviour. This model was established as an alternative to ex vivo bindi
Autor:
M I, Strakhova, C A, Cuff, A M, Manelli, T L, Carr, D G, Witte, J L, Baranowski, T A, Vortherms, T R, Miller, L, Rundell, M J, McPherson, R M, Adair, A A, Brito, B M, Bettencourt, B B, Yao, J M, Wetter, K C, Marsh, H, Liu, M D, Cowart, J D, Brioni, T A, Esbenshade
Publikováno v:
British journal of pharmacology. 157(1)
The histamine H4 receptor is widely expressed in cells of immune origin and has been shown to play a role in a variety of inflammatory processes mediated by histamine. In this report, we describe the in vitro and in vivo anti-inflammatory properties
Publikováno v:
British journal of pharmacology. 154(6)
The histamine H3 receptor, first described in 1983 as a histamine autoreceptor and later shown to also function as a heteroreceptor that regulates the release of other neurotransmitters, has been the focus of research by numerous laboratories as it r
Autor:
B. R. Estvander, T. R. Miller, J. L. Baranowski, A. A. Hancock, T. A. Esbenshade, R. Sharma, K. M. Krueger
Publikováno v:
Inflammation research : official journal of the European Histamine Research Society ... [et al.]. 56
Autor:
Ramin Faghih, T. R. Miller, P. B. Jacobson, J. K. Pratt, Marlon D. Cowart, R. W. Dickinson, G. Krishna, M. E. Brune, C. A. McDowell, K. M. Krueger, B. A. Droz, M. S. Diehl, R. Shapiro, E. N. Bush, T. A. Fey, T. A. Esbenshade, A. A. Hancock, V. E. Knourek-Segel
Publikováno v:
Inflammation research : official journal of the European Histamine Research Society ... [et al.]. 54
Autor:
G B, Fox, T A, Esbenshade, J B, Pan, K E, Browman, M, Zhang, M E, Ballard, R J, Radek, H, Miner, R S, Bitner, K M, Krueger, B B, Yao, R, Faghih, L E, Rueter, V A, Komater, K U, Drescher, M J, Buckley, J P, Sullivan, M D, Cowart, M W, Decker, A A, Hancock
Publikováno v:
Inflammation research : official journal of the European Histamine Research Society ... [et al.]. 54
Autor:
Y. L. Bennani, S. Cassar, David G. Witte, T. L. Carr, Ramin Faghih, A. A. Hancock, T. A. Esbenshade, B. Bei Yao, C. H. Kang, Thomas R. Miller, B. W. Surber
Publikováno v:
Neuropharmacology. 50(4)
Selective radioligands for histamine H(3) receptors have been used to characterize H(3) receptor pharmacology by radioligand binding assays and to determine H(3) receptor distribution by tissue autoradiography. Here we report the synthesis and recept